Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis
- PMID: 1554833
- DOI: 10.1093/clinids/14.2.472
Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis
Abstract
Candida krusei has become an increasingly important invasive pathogen, particularly in immunocompromised patients. Previous experimental and clinical experience suggest that C. krusei has a low propensity for hematogenously infecting the eye. We report 10 cases of fungemia due to C. krusei at our institutions, including three cases of endophthalmitis due to C. krusei. Fungemia was associated with nodular skin lesions in all seven patients with neutropenia and occurred despite administration of antifungal prophylaxis or empirical therapy. None of the patients apparently died as a direct result of C. krusei fungemia. Treatment with amphotericin B resulted in resolution of endophthalmitis, although one patient required vitrectomy. Early institution of aggressive therapy with amphotericin B may alter the course and improve the prognosis of C. krusei infection, particularly in immunocompromised patients.
Similar articles
-
Hematogenous endophthalmitis due to Candida tropicalis: report of two cases and review.Clin Infect Dis. 1993 Aug;17(2):270-2. doi: 10.1093/clinids/17.2.270. Clin Infect Dis. 1993. PMID: 8399881 Review.
-
A case of fungemia due to Candida krusei.Nihon Ishinkin Gakkai Zasshi. 1999;40(1):15-20. doi: 10.3314/jjmm.40.15. Nihon Ishinkin Gakkai Zasshi. 1999. PMID: 9929577
-
Candida krusei fungemia. An escalating serious infection in immunocompromised patients.Arch Intern Med. 2000 Sep 25;160(17):2659-64. doi: 10.1001/archinte.160.17.2659. Arch Intern Med. 2000. PMID: 10999981
-
Bilateral Candida endophthalmitis accompanying Candida lusitaniae bloodstream infection: A case report.J Infect Chemother. 2018 Feb;24(2):147-149. doi: 10.1016/j.jiac.2017.10.002. Epub 2017 Oct 26. J Infect Chemother. 2018. PMID: 29102349
-
Endophthalmitis caused by non-albicans species of Candida.Rev Infect Dis. 1991 Mar-Apr;13(2):281-7. doi: 10.1093/clinids/13.2.281. Rev Infect Dis. 1991. PMID: 2041961 Review.
Cited by
-
Typing of Candida krusei clinical isolates by restriction endonuclease analysis and hybridization with CkF1,2 DNA probe.J Clin Microbiol. 1994 Jul;32(7):1691-9. doi: 10.1128/jcm.32.7.1691-1699.1994. J Clin Microbiol. 1994. PMID: 7929759 Free PMC article.
-
Successful treatment of catheter-associated fungemia due to Candida krusei and Trichosporon beigelii in a leukemic patient receiving prophylactic itraconazole.Eur J Clin Microbiol Infect Dis. 1995 Feb;14(2):148-9. doi: 10.1007/BF02111878. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7758485 No abstract available.
-
Susceptibility testing of fungi: current status of the standardization process.Antimicrob Agents Chemother. 1993 Dec;37(12):2517-21. doi: 10.1128/AAC.37.12.2517. Antimicrob Agents Chemother. 1993. PMID: 8109912 Free PMC article. Review. No abstract available.
-
Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.Med Oncol. 1996 Dec;13(4):223-31. doi: 10.1007/BF02990935. Med Oncol. 1996. PMID: 9152973 Review.
-
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.Antimicrob Agents Chemother. 1995 Mar;39(3):775-7. doi: 10.1128/AAC.39.3.775. Antimicrob Agents Chemother. 1995. PMID: 7793892 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical